Physostigmine in recovery from anaesthesia

Area of Science:

• Anesthesiology
• Military Medicine
• Pharmacology

Background:

• Intravenous ketamine anesthesia is utilized by the British military in field settings.
• A significant challenge with ketamine anesthesia is its unpredictable patient recovery profile.
• Optimizing recovery is crucial for timely patient management in austere environments.

Purpose of the Study:

• To evaluate the efficacy of physostigmine/glycopyrronium mixture in mitigating prolonged recovery times associated with ketamine anesthesia.
• To compare recovery profiles between patients receiving physostigmine/glycopyrronium and those receiving a saline placebo post-ketamine anesthesia.

Main Methods:

• A cohort of 28 ASA 1 patients undergoing ketamine anesthesia using a standard British military technique were studied.
• Patients were randomized at the termination of anesthesia to receive either a physostigmine/glycopyrronium mixture or an equivalent volume of 0.9% saline.
• Recovery times and other variables were monitored and compared between the two groups.

Main Results:

• A statistically significant difference in recovery times was observed between the physostigmine/glycopyrronium group and the saline group (p < 0.001).
• No significant differences were found in other monitored variables between the treatment groups.
• The administration of physostigmine markedly reduced the unpredictable recovery associated with ketamine anesthesia.

Conclusions:

• Physostigmine administration significantly accelerates recovery following ketamine anesthesia in a military field context.
• The improved recovery profile may enable earlier patient evacuation, particularly beneficial in trauma anesthesia scenarios.
• This intervention offers a potential strategy to enhance patient care and operational efficiency in deployed settings.